Therapeutic plasma exchange in pediatric intensive care: Indications, results and complications

Guntulu Sık1, Asuman Demirbuga1, Agageldi Annayev1

  • 1Acıbadem Mehmet Ali Aydınlar University, School of Medicine, Department of Pediatric Intensive Care, Istanbul, Turkey.

Insights

Therapeutic plasma exchange (TPE) is safe and effective for critically ill children, with an overall survival rate of 78.5%. This pediatric intensive care study highlights sepsis and hematological diseases as key indications for TPE.

Area of Science:

  • Pediatric Critical Care Medicine
  • Extracorporeal Therapies
  • Intensive Care Unit Management

Background:

  • Therapeutic plasma exchange (TPE) is a recognized treatment for various conditions.
  • Application of TPE in pediatric patients presents unique challenges due to access and technical considerations.
  • Critically ill children often require advanced life support, including TPE, for severe conditions.

Purpose of the Study:

  • To evaluate the safety, clinical indications, and outcomes of TPE in critically ill pediatric patients.
  • To identify patient subgroups and conditions associated with TPE efficacy and complications.
  • To assess the feasibility and impact of TPE in a tertiary care pediatric intensive care unit.

Main Methods:

  • Retrospective analysis of all TPE procedures performed in a pediatric intensive care unit from 2015 to 2019.
  • Inclusion of 135 critically ill pediatric patients requiring TPE, with detailed data collection on demographics, indications, and treatments.
  • Evaluation of procedural complications, replacement fluids, anticoagulants, and survival rates.

Main Results:

  • A total of 635 TPE procedures were performed. Sepsis with multiple organ failure (44.4%) was the primary indication, followed by hematological (19.2%) and neurological (9.6%) diseases.
  • The overall survival rate was 78.5%. Non-survivors exhibited significantly higher rates of organ failure, PRISM scores, and need for invasive ventilation.
  • Procedural complications occurred in 16.3% of cases, with fresh frozen plasma (90.4%) and acid citrate dextrose solution (79.3%) being the most common replacement fluid and anticoagulant, respectively.

Conclusions:

  • Therapeutic plasma exchange is a safe and effective treatment modality for critically ill pediatric patients when performed in facilities with appropriate medical and technical resources.
  • While TPE in children carries inherent risks, experienced centers can minimize complications.
  • Outcomes are generally favorable, but vary based on the underlying clinical indication and patient severity.

Related Concept Videos

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
128
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
647
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
168
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
234
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
209
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
152